ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Non-Small-Cell Lung Carcinoma
Neoplasm Metastasis
Ovarian Cancer
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer

Breast Cancer trials near Valencia, VC, ESP:

Adjuvant Palbociclib in Elderly Patients With Breast Cancer (Appalaches)

adjuvant systemic treatment instead of adjuvant chemotherapy followed by endocrine therapy in older patients with stage II-III ER+/HER2- early breast...

Active, not recruiting
Breast Cancer Stage II
Breast Cancer Stage III
Drug: Palbociclib
Drug: Docetaxel / cyclophosphamide

Phase 2

European Organisation for Research and Treatment of Cancer (EORTC)

Valencia, Spain and 72 other locations

in patients with Human Epidermal Growth Factor Receptor 2 (HER2)-low breast cancer with active brain metastases.This study will ana...

Active, not recruiting
Breast Cancer
Metastatic Breast Cancer
Drug: Trastuzumab-Deruxtecan (T-DXd)

Phase 2

MedSIR

Valencia, Valencia, Spain and 12 other locations

-positive / HER2-negative breast cancer which has spread beyond the original tumor and/or to other organs.During this stud...

Active, not recruiting
Breast Cancer Recurrent
Drug: Standard endocrine therapy
Drug: Palbociclib 125mg

Phase 3

ETOP IBCSG Partners Foundation

Valencia, Spain and 52 other locations

the primary and metastatic (or relapsed) tumor will be collected for central analyses, together with blood, serum and plasma samples. Any s ...

Enrolling
Metastatic Breast Cancer
Procedure: metastatic lesion biopsy
Breast International Group

Valencia, Spain and 52 other locations

A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...

Active, not recruiting
ER+ HER2- Advanced Breast Cancer
Drug: AZD9833 with palbociclib
Drug: AZD9833 with capivasertib

Phase 1

AstraZeneca
AstraZeneca

Valencia, Spain and 16 other locations

number of mutations per coding area of a tumor genome). The HER2-E and Basal-like profiles have been associated with high mutational burden ...

Active, not recruiting
Breast Cancer
Drug: Atezolizumab + Trastuzumab + Vinorelbine

Phase 2

SOLTI

Valencia, Spain and 14 other locations

This study to learn more about olaparib and olaparib plus durvalumab combination therapy and also to better understand the studied disease, breast...

Active, not recruiting
Breast Cancer
Combination Product: Neoadjuvant combination therapy with olaparib plus durvalumab
Drug: Neoadjuvant Olaparib monotherapy group

Phase 2

AstraZeneca
AstraZeneca

Valencia, Spain and 36 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Valencia, Spain and 107 other locations

with pathology-confirmed HR-positive/HER2-negative metastatic breast cancer (MBC) following progression on or after at least two pr...

Enrolling
Hormone Receptor Positive HER-2 Negative Breast Cancer
Metastatic Breast Cancer
Drug: Alisertib
Drug: Endocrine therapy

Phase 2

Puma Biotechnology
Puma Biotechnology

Valencia, Spain and 52 other locations

3CA)/ Phosphatase and Tensin Homolog (PTEN)-altered, unresectable locally advanced or metastatic metaplastic breast carcinoma (MpBC) patient...

Active, not recruiting
Breast Cancer
Metastatic Breast Cancer
Drug: MEN1611
Drug: Eribulin

Phase 2

MedSIR

Valencia, Spain and 12 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems